文献速递胸部技术与安全CT

COVID-19患者入院时视觉肺损伤CT评分与30天死亡率的关系

Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality.
PubMed 文献 · Eur Radiol · 2021-04-29

该单中心前瞻性队列研究纳入210例确诊COVID-19患者,在首次胸部CT上采用简易视觉肺损伤CT评分(vldCTs,无需软件)评估5个肺叶的磨玻璃影和实变影范围(每叶0-4分,总分0-20分)。结果显示vldCTs在非存活者中显著更高,区分存活与非存活的AUC为0.72(95%CI 0.628-0.807,p<0.001),最佳截断值为7;vldCTs≥7与30天死亡率升高独立相关(HR 3.16,95%CI 1.50-6.43,p=0.001),不受年龄、呼吸频率、氧饱和度和合并症影响。

要点

  • 入院胸部CT视觉肺损伤评分vldCTs≥7提示30天死亡风险增高(HR 3.16)。
  • vldCTs无需软件,在5个肺叶评估磨玻璃影和实变范围,总分0-20分。
  • vldCTs区分存活与非存活的AUC为0.72,最佳截断值7。

关键影像表现/征象

  • 在5个肺叶中视觉评估磨玻璃影和/或实变影的存在与范围,每叶按百分比评分0-4分。
  • vldCTs在非存活者中显著高于存活者。
  • vldCTs≥7与vldCTs<7患者相比,出院率(98[85.2%] vs 49[51.6%],p<0.001)和30天死亡率(36[37.9%] vs 12[12.4%],p<0.001)差异显著。

诊断标准与关键数值

  • vldCTs区分存活与非存活的AUC为0.72(95%CI 0.628-0.807,p<0.001)。
  • 最佳截断值vldCTs为7。
  • vldCTs≥7时30天死亡率HR为3.16(95%CI 1.50-6.43,p=0.001),独立于年龄、呼吸频率、氧饱和度和合并症。

临床应用与阅片要点

  • 建议将vldCTs纳入COVID-19风险分层算法。
  • 建议在结构化胸部CT报告中采用标准化视觉评分,便于放射科医师规范阅读。
  • 该评分无需软件,可在入院首次胸部CT上快速完成。

局限性

  • 单中心前瞻性队列研究,样本量210例,外部推广性需验证。
  • 视觉评估主观性可能影响评分一致性。
  • 未报告评分者间一致性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Chest CT has been widely used to screen and to evaluate the severity of COVID-19 disease in the early stages of infection without severe acute respiratory syndrome, but no prospective data are available to study the relationship between extent of lung damage and short-term mortality. The objective was to evaluate association between standardized simple visual lung damage CT score (vldCTs) at admission, which does not require any software, and 30-day mortality.

METHODS: In a single-center prospective cohort of COVID-19 patients included during 4 weeks, the presence and extent of ground glass opacities(GGO), consolidation opacities, or both of them were visually assessed in each of the 5 lung lobes (score from 0 to 4 per lobe depending on the percentage and out of 20 per patient = vldCTs) after the first chest CT performed to detect COVID-19 pneumonia.

RESULTS: Among 210 confirmed COVID-19 patients, the number of survivors and non-survivors was 162 (77%) and 48 (23%), respectively at 30 days. vldCTs was significantly higher in non-survivors, and the AUC of vldCTs to distinguish survivors and non-survivors was 0.72 (95%CI 0.628-0.807, p < 0.001); the best cut-off vldCTs value was 7. During follow-up, significant differences in discharges and 30-day mortality were observed between patients with vldCTs ≥ 7 versus vldCTs < 7: (98 [85.2%] vs 49 [51.6%]; p < 0.001 and 36 [37.9%] vs 12 [12.4%]; p < 0.001, respectively. The 30-day mortality increased if vldCTs ≥ 7 (HR, 3.16 (1.50-6.43); p = 0.001), independent of age, respiratory rate and oxygen saturation levels, and comorbidities at admission.

CONCLUSIONS: By using chest CT in COVID-19 patients, extensive lung damage can be visually assessed with a score related to 30-day mortality independent of conventional risk factors of the disease.

KEY POINTS: • In non-selected COVID-19 patients included prospectively during 4 weeks, the extent of ground glass opacities(GGO) and consolidation opacities evaluated by a simple visual score was related to 30-day mortality independent of age, respiratory rate, oxygen saturation levels, comorbidities, and hs-troponin I level at admission. • This severity score should be incorporated into risk stratification algorithms and in structured chest CT reports requiring a standardized reading by radiologists in case of COVID-19.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Charpentier E, Soulat G, Fayol A, et al. Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality. Eur Radiol. 2021. PMID: 33914118. doi:10.1007/s00330-021-07938-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。